Orexin A Stimulates Hypothalamic–Pituitary–Adrenal (HPA) Axis Function, but not Food Intake, in the Absence of Full Hypothalamic NPY-ergic Activity
- 1 January 2005
- journal article
- Published by Springer Nature in Endocrine
- Vol. 26 (2) , 099-106
Abstract
Neonatal monosodium l-glutamate (MSG) treatment destroys hypothalamic arcuate nucleus neuronal bodies, thus inducing several metabolic abnormalities. As a result, rats develop a phenotype characterized by hyperleptinemia and by impaired NPY but normal prepro-orexin hypothalamic mRNAs expression. Thus, our study was designed to explore whether hypothalamic effects of orexin A on food intake and glucocorticoid production develop in the absence of full hypothalamic NPY-ergic activity. For this purpose we evaluated, in control and MSG-treated rats, the consequences of intracere-broventricular (icv) orexin A administration on food intake and changes in circulating levels of ACTH and glucocorticoid. Our results indicate that orexin A icv treatment stimulated hypothalamic-pituitary-adrenal (HPA) axis activity in both MSG-damaged and normal animals, with this response even more pronounced in neurotoxin-damaged rats. Conversely, food intake was only enhanced by icv orexin A injection in normal rats. Our study further supports that acute hypothalamic effects of orexin A on food intake and glucocorticoid production are due to independent neuronal systems. While intact arcuate nucleus activity is needed for the orexinergic effect induced by icv orexin A administration, conversely, orexin A-stimulated HPA axis function takes place even in the absence of full NPY-ergic activity.Keywords
This publication has 49 references indexed in Scilit:
- Differential Distribution and Regulation of OX1 and OX2 Orexin/Hypocretin Receptor Messenger RNA in the Brain upon FastingHormones and Behavior, 2000
- The hypocretins are weak agonists at recombinant human orexin‐1 and orexin‐2 receptorsBritish Journal of Pharmacology, 2000
- Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action1This study was presented in part at the 28th Annual Meeting of the Society for Neuroscience, Los Angeles, CA, in November 1998.1Brain Research, 1999
- Distribution of orexin neurons in the adult rat brainBrain Research, 1999
- Neonatal monosodium glutamate treatment alters both the activity and the sensitivity of the rat hypothalamo-pituitary-adrenocortical axisJournal of Endocrinology, 1994
- Changes in the Hypothalamo-Corticotrope Axis after Bilateral Adrenalectomy: Evidence for a Median Eminence Site of Glucocorticoid ActionNeuroendocrinology, 1991
- Neonatal Treatment with Monosodium Glutamate Increases Plasma Corticosterone in the RatNeuroendocrinology, 1988
- Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the ratBrain Research, 1987
- Acute Effect of Oral and Subcutaneous Administration of Monosodium Glutamate on the Arcuate Nucleus of the Hypothalamus in Mice and RatsNature, 1971
- Effect of Monosodium Glutamate on Some Endocrine FunctionsNeuroendocrinology, 1971